|
All Neuromuscular Disease
Citations 151-158 of 158 total displayed.
|
Past content
(since Jan 2000):
|
- ARTICLES
Frequency and stability of the myotonic dystrophy type 1 premutation
- L. Martorell, D.G. Monckton, A. Sanchez, A. Lopez de Munain, and M. Baiget
Neurology 2001; 56: 328-335.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neuropathy and IgM M-proteins: Prognostic value of antibodies to MAG, SGPG, and sulfatide
- M. Eurelings, K.G.M. Moons, N.C. Notermans, L.D. Sasker, A.E.J. De Jager, A.R. Wintzen, J.H.J. Wokke, and L.H. Van den Berg
Neurology 2001; 56: 228-233.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Incidence of ALS in Italy: Evidence for a uniform frequency in Western countries
-
Neurology 2001; 56: 239-244.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Sural nerve T-cell receptor Vß gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy
- W.M.J. Bosboom, L.H. Van den Berg, I. Mollee;, L.D. Sasker;, J. Jansen, J.H.J. Wokke, and T. Logtenberg
Neurology 2001; 56: 74-81.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Sensory Guillain–Barré syndrome
- Shin J. Oh, Chris LaGanke, and Gwen C. Claussen
Neurology 2001; 56: 82-86.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Inclusion body myositis: Expression of extracellular signal-regulated kinase and its substrate
- S. Nakano, A. Shinde, S. Kawashima, S. Nakamura, I. Akiguchi, and J. Kimura
Neurology 2001; 56: 87-93.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
- V. Chaudhry, D. R. Cornblath, J. W. Griffin, R. O’Brien, and D. B. Drachman
Neurology 2001; 56: 94-96.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome
- B. Buchwald, J. Bufler, M. Carpo, F. Heidenreich, R. Pitz, J. Dudel, E. Nobile–Orazio, and K.V. Toyka
Neurology 2000; 56: 67-74.
[Abstract]
[Full text]
[PDF]
|
|
